Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation lmmunoenzymatic methods for the detection of antibodies to citrullinated proteins

被引:76
作者
Bizzaro, Nicola
Tonutti, Elio
Tozzoli, Renato
Villalta, Danilo
机构
[1] Osped Civile, Lab Patol Clin, I-33028 Tolmezzo, Italy
[2] Hosp Tolmezzo, Clin Pathol Lab, Tolmezzo, Italy
[3] Hosp Univ S Maria Misericordia, Udine, Italy
[4] Hosp Latisana, Lab Clin Chem & Microbiol, Latisana, Italy
[5] Hosp S Maria Angeli, Clin Immunol & Virol, Pordenone, Italy
关键词
D O I
10.1373/clinchem.2007.087569
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Measurement of antibodies to citrullinated peptides or proteins (CP) is a new test for the diagnosis of rheumatoid arthritis (RA). We analyzed the analytical characteristics and diagnostic accuracy of commercially available methods. Methods: We studied 11 commercially available 2nd and 3rd-generation methods that used various citrullinated antigen substrates: synthetic cyclic peptides, recombinant rat filaggrin, mutated human vimentin, and Epstein-Barr virus- or IgG-derived peptides. We assessed imprecision by measuring samples with low, intermediate, and high concentrations 5 times on each of 5 days. We measured CPs by each of the assays in 100 serum samples from patients with RA and in 202 samples from healthy persons or patients with other autoimmune, viral, or neoplastic diseases. Results: The between-run imprecision (CV) of the methods was between 0.4% and 22%, and the repeatability (within-run imprecision) was 0.5%-19%. The areas under the ROC curves varied between 0.79 (95% CI, 0.72-0.85) and 0.92 (0.88-0.95). At a fixed specificity of 98.5%, the sensitivities ranged from 41% (95% Cl, 31%51%) to 74% (64%-82%). Sensitivities and specificities varied markedly at the manufacturer's suggested cutoffs. Most false-positive results were recorded in patients with viral infections. The methods that use the original synthetic cyclic CP gave the best and very similar performances, although these methods use different components in their reagent sets (conjugate, type of substrate, dilution, and washing buffers). This finding shows that the antigenic source is the most important variable in determining the diagnostic accuracy of the methods. Conclusions: The analytical imprecision and diagnostic accuracies of commercially available methods for the detection of anti-CP antibodies differ. Careful selection of methods is needed. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:1527 / 1533
页数:7
相关论文
共 37 条
  • [1] [Anonymous], 2005, EP15A2 CLSI
  • [2] Anzilotti C, 2006, J RHEUMATOL, V33, P647
  • [3] Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review
    Avouac, J.
    Gossec, L.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 845 - 851
  • [4] Bizzaro N, 2001, CLIN CHEM, V47, P1089
  • [5] Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement
    Bombardieri, M
    Alessandri, C
    Labbadia, G
    Iannuccelli, C
    Carlucci, F
    Riccieri, V
    Paoletti, V
    Valesini, G
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (02) : R137 - R141
  • [6] The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration
    Bossuyt, PM
    Reitsma, JB
    Bruns, DE
    Gatsonis, CA
    Glasziou, PP
    Irwig, LM
    Moher, D
    Rennie, D
    de Vet, HCW
    Lijmer, JG
    [J]. CLINICAL CHEMISTRY, 2003, 49 (01) : 7 - 18
  • [7] Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497
  • [8] Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
    Dejaco, Christian
    Klotz, Werner
    Larcher, Heike
    Duftner, Christina
    Schirmer, Michael
    Herold, Manfred
    [J]. ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
  • [9] Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases
    Dubucquoi, S
    Solau-Gervais, E
    Lefranc, D
    Marguerie, L
    Sibilia, J
    Goetz, J
    Dutoit, V
    Fauchais, AL
    Hachulla, E
    Flipo, RM
    Prin, L
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (04) : 415 - 419
  • [10] Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis
    Fernández-Suárez, A
    Reneses, S
    Wichmann, I
    Criado, R
    Núñez, A
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (11) : 1234 - 1239